Thomas A. Fitzgerald

Insider Reports History

Entity
Individual
Location
C/O Transcode Therapeutics, Inc., 6 Liberty Square, #2382, Boston, MA
Signature
/s/ Thomas A. Fitzgerald
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas A. Fitzgerald:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Transcode Therapeutics, Inc. Interim CEO, CFO, Director Common Stock 56.3K $28.7K $0.51 Sep 28, 2023 Direct
Transcode Therapeutics, Inc. Interim CEO, CFO, Director Stock Option (right to buy) 650K Jun 14, 2024 Direct

Insider Reports Filed by Thomas A. Fitzgerald

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAZ Transcode Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Interim CEO, CFO, Director
RNAZ Transcode Therapeutics, Inc. Sep 28, 2023 1 $25.2K 4 Oct 2, 2023 Chief Financial Officer, Director
RNAZ Transcode Therapeutics, Inc. May 19, 2023 1 $0 4 May 19, 2023 Chief Financial Officer, Director
RNAZ Transcode Therapeutics, Inc. Dec 12, 2022 1 $0 4 Dec 14, 2022 Chief Financial Officer, Director
RNAZ Transcode Therapeutics, Inc. Jun 16, 2022 1 $15.2K 4 Jun 17, 2022 Chief Financial Officer, Director
RNAZ Transcode Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 2, 2022 Chief Financial Officer, Director
RNAZ Transcode Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Financial Officer, Director
RNAZ Transcode Therapeutics, Inc. Jul 8, 2021 0 $0 3 Jul 8, 2021 VP, Chief Financial Officer, Director